JABLX
Price
$55.40
Change
+$0.18 (+0.33%)
Updated
Oct 17 closing price
Net Assets
9.52B
RLBCX
Price
$38.75
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

JABLX vs RLBCX

Header iconJABLX vs RLBCX Comparison
Open Charts JABLX vs RLBCXBanner chart's image
Janus Henderson VIT Balanced Instl
Price$55.40
Change+$0.18 (+0.33%)
VolumeN/A
Net Assets9.52B
American Funds American Balanced R3
Price$38.75
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
JABLX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
JABLX vs. RLBCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JABLX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 265B vs. JABLX (9.52B). JABLX pays higher dividends than RLBCX: JABLX (1.94) vs RLBCX (1.49). JABLX was incepted earlier than RLBCX: JABLX (32 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than JABLX (0.62). JABLX is a more actively managed with annual turnover of: 83.00 vs. RLBCX (44.00). JABLX has a lower initial minimum investment than RLBCX: JABLX (0) vs RLBCX (250). JABLX annual gain was more profitable for investors over the last year : 8.98 vs. RLBCX (8.34). JABLX return over 5 years is better than : 43.32 vs. RLBCX (40.24).
JABLXRLBCXJABLX / RLBCX
Total Expense Ratio0.620.8970%
Annual Report Gross Expense Ratio0.620.8970%
Fund Existence32 years23 years-
Gain YTD9.30614.36465%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets9.52B265B4%
Annual Yield % from dividends1.941.49130%
Returns for 1 year8.988.34108%
Returns for 3 years50.6649.26103%
Returns for 5 years43.3240.24108%
Returns for 10 years120.9372.18168%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBM3.520.07
+2.03%
Psyence Biomedical Ltd
CVGW23.810.14
+0.59%
Calavo Growers
SWK67.85-0.06
-0.09%
Stanley Black & Decker
IQ2.03-0.03
-1.46%
iQIYI
PMVP1.40-0.04
-2.78%
PMV Pharmaceuticals